Form SCHEDULE 13D/A Meridian Holdings Inc./N Filed by: Goodman Anthony Brian

Mr. Goodman's business address is 3651 Lindell Road, Suite D131, Las Vegas, NV 89103. Luxor' business address is 3651 Lindell Road, Suite D131, Las Vegas, NV 89103.

Anthony Brian Goodman's principal business occupation is Company Director. Luxor is a Nevada limited liability company which develops and owns intellectual property.

The Reporting Persons have not, during the last five years, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).

The Reporting Persons have not, during the last five years, been party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

Mr. Goodman is a citizen of Australia. Luxor is a Nevada limited liability company.

Item 3 is hereby amended and supplemented as follows: This Amendment reports the transactions described below, as well as: the sale by the Reporting Persons in open market transactions from June 30, 2025, through June 12, 2026, of 210,730 shares of Common Stock of the Issuer as described on Schedule A. On November 25, 2025, the Issuer entered into a Severance and Release Agreement (the "Severance Agreement") with Mr. Goodman, pursuant to which (i) the Issuer and Mr. Goodman mutually agreed to terminate Mr. Goodman's employment with the Issuer effective as of December 12, 2025, unless otherwise agreed between the parties (the "Termination Date"), and (ii) the Issuer agreed to pay Mr. Goodman a $951,750 severance payment (representing eighteen months of Mr. Goodman's base salary ($434,500), plus Mr. Goodman's 2025 targeted bonus ($300,000)) and $46,792 in accrued, unused vacation pay. Pursuant to the Severance Agreement, the Issuer agreed to use commercially reasonable efforts to reasonably assist Mr. Goodman in the conversion of his shares of Series B Preferred Stock into shares of Issuer Common Stock, which have been fully-converted to date. The Issuer also agreed to reimburse Mr. Goodman up to $10,000 in attorney's fees and costs incurred in connection with the Severance Agreement. All 300,000 unvested restricted stock units (RSUs) previously granted to Mr. Goodman became 100% vested as of the Termination Date and were issued on such date. On December 12, 2025, Mr. Goodman converted all 1,000 outstanding shares of the Issuer's Series B Voting Preferred Stock which he held into 83,333 shares of the Issuer's Common Stock. Effective December 12, 2025, Mr. Goodman resigned as President, Chief Executive Officer, Principal Executive Officer, Secretary, Treasurer, and as a member of the Board of Directors of the Issuer and each of its subsidiaries.

Item 4 is hereby amended and restated in its entirety to read as follows: The information set forth in Item 3 is hereby incorporated by reference into this Item 4. The Reporting Persons acquired the securities pursuant to the transactions described in Item 3 above. In the future, depending on general market and economic conditions affecting the Issuer and other relevant factors, the Reporting Persons may purchase or acquire additional securities of the Issuer or dispose of some or all of the securities they currently own from time to time in open market transactions, private transactions or otherwise. Except as may occur in the ordinary course of business of the Company, the Reporting Persons do not currently have any plans or proposals which relate to or would result in the following described: (a) The acquisition by any person of additional securities of the Issuer, or the disposition of securities of the Issuer; (b) An extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the Issuer or any of its subsidiaries; (c) A sale or transfer of a material amount of assets of the Issuer or any of its subsidiaries; (d) Any change in the present board of directors or management of the Issuer, including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the board; (e) Any material change in the present capitalization or dividend policy of the Issuer; (f) Any other material change in the Issuer's business or corporate structure, including but not limited to, if the Issuer is a registered closed-end investment company, any plans or proposals to make any changes in its investment policy for which a vote is required by section 13 of the Investment Company Act of 1940; (g) Changes in the Issuer's charter, bylaws or instruments corresponding thereto or other actions which may impede the acquisition of control of the Issuer by any person; (h) Causing a class of securities of the Issuer to be delisted from a national securities exchange or to cease to be authorized to be quoted in an inter-dealer quotation system of a registered national securities association; (i) A class of equity securities of the Issuer becoming eligible for termination of registration pursuant to section 12(g)(4) of the Act; or (j) Any action similar to any of those enumerated above. The Reporting Persons retain the right to change their investment intent, and may, from time to time, acquire additional shares of Common Stock or other securities of the Company, or sell or otherwise dispose of (or enter into a plan or arrangements to sell or otherwise dispose of), all or part of the shares of Common Stock or other securities of the Company, if any, beneficially owned by them, in any manner permitted by law. On March 28, 2025, Mr. Goodman entered into a Rule 10b5-1 Sales Plan with Oppenheimer & Co. Inc. (the "10b5-1 Plan") pursuant to Rule 10b5-1 of the Exchange Act, for the purpose of selling shares of Common Stock in open market transactions. The description of the 10b5-1 Plan set forth in Item 6 below is incorporated herein by reference in its entirety. On September 5, 2025, the 10b5-1 Plan was terminated pursuant to its terms. The Reporting Persons have no current plans or proposals that relate to or would result in any of the changes or transactions enumerated in subsections (a) - (j) of Item 4 of the General Instructions for Complying with Schedule 13D, although, depending on the factors discussed herein, the Reporting Persons may change their purpose or formulate different plans or proposals with respect thereto at any time. The Reporting Persons, however, will take such actions with respect to the Reporting Persons' investments in the Issuer as deemed appropriate in light of existing circumstances from time to time and reserve the right to acquire or dispose of securities of the Issuer, to enter into hedging relationships with respect to such securities, or to formulate other purposes, plans, or proposals in the future depending on market conditions and/or other factors. The Reporting Persons acquired, and presently hold, the securities reported herein for investment purposes.

The aggregate number and percentage of the class of securities beneficially owned by each Reporting Person are set forth on rows 11 and 13 of the cover pages of this Schedule 13D and are incorporated herein by this reference thereto.

The aggregate number of shares of Common Stock beneficially owned by each Reporting Person and, for each Reporting Person, the number of shares as to which there is sole power to vote or to direct the voting thereof, shared power to vote or to direct the voting thereof, sole power to dispose or to direct the disposition thereof, or shared power to dispose or to direct the disposition thereof, are set forth on rows 7 through 11 of the cover pages of this Schedule 13D and are incorporated herein by this reference thereto.

The information in Item 3 is incorporated by reference into this Item 5(c).

No other person has the right to receive or the power to direct the receipt of dividends from or the proceeds from the sale of the securities beneficially owned by the Reporting Persons.

N/A.

Item 6 as amended through Amendment No. 6, is hereby amended and supplemented by adding the following at the end thereof: Pursuant to the 10b5-1 Plan, Mr. Goodman could sell up to 41,6667 shares of Common Stock beneficially owned by Mr. Goodman, on the open market, subject to the satisfaction of certain conditions, including, among others, the Company's trading price. All sales under the 10b5-1 Plan were to be made in the discretion of Oppenheimer and in accordance with the terms, conditions and restrictions of the 10b5-1 Plan. Pursuant to the 10b5-1 Plan, potential sales began on June 30, 2025 and continued until September 5, 2025, or until all of the shares of Common Stock to be sold under the 10b5-1 Plan are sold or the 10b5-1 Plan was otherwise terminated. The foregoing description of the 10b5-1 Plan is qualified in its entirety by the full text of the 10b5-1 Plan, the form of which is included as an exhibit to this Schedule 13D and is incorporated herein by reference.

1 - Joint Filing Agreement by and among Mr. Anthony Brian Goodman and Luxor Capital, LLC, dated March 12, 2021 - https://www.sec.gov/Archives/edgar/data/1437925/000147793221001562/gmgi_ex991.htm 2 - Form of Golden Matrix Group, Inc. RSU Award Grant Notice and RSU Award Agreement (2023 Equity Incentive Plan) (Filed as Exhibit 10.1 to the Current Report on Form 8-K filed by the Company with the Securities and Exchange Commission on January 16, 2025, and incorporated by reference herein) - https://www.sec.gov/Archives/edgar/data/1437925/000147793225000303/gmgi_ex101.htm 3 - Form of March 2025 Rule 10b5-1 Sales Plan - Filed as an exhibit to Amendment No. 8 to the Schedule 13D and incorporated by reference herein 4 - Schedule A - Transactions undertaken by the Reporting Persons in open market transactions from June 30, 2025, through June 12, 2026